DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells

Cardiovascular complications are the leading cause of mortality and morbidity in type 2 diabetes patients. Diabetes greatly increases the risk of heart disease; therefore, the management of diabetes often involves the prevention of heart disease. DPP-4 inhibitors have been proven to be the effective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yunxiang Ma, Junkai Wang, Changhua Wang, Qiong Zhang, Yannan Xu, Huajin Liu, Xia Xiang, Jiangwei Ma
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2019-12-01
Colecção:Artificial Cells, Nanomedicine, and Biotechnology
Assuntos:
DPP-4
anagliptin
H9C2 cells
cardiomyocyte protection
Acesso em linha:https://www.tandfonline.com/doi/10.1080/21691401.2019.1652624
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados